Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 6/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.43 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.43 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.43 |
| ▸ | HTR1A | P08908 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.43 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.43 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.43 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.43 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.43 |
| ▸ | GALR3 | O60755 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL366431 | 0.98 | GALR3 (0.45) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| Iodide SCHEMBL10787028 | 0.98 | CHRM5 (0.41) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| Hydrochloric Acid SCHEMBL366719 | 0.98 | CHRM5 (0.45) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| Sulfuric Acid SCHEMBL9636228 | 0.88 | CHRM5 (0.39) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| Hydrochloric Acid SCHEMBL11134213 | 0.85 | APEX1 (0.39) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL5492345 | 0.84 | POLB (0.37) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL1598351 | 0.82 | DNM1 (0.33) | CHRNA7CHRNB4CHRNA3KMT2A | |
| SCHEMBL1597437 | 0.80 | CHRM4 (0.33) | CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL631462 | 0.79 | HSD17B10 (0.37) | TSHRMEN1KMT2A | |
| SCHEMBL4051767 | 0.79 | DNM1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3600220-B1 | POLYPHENOLS/PEG BASED HYDROGEL SYSTEM FOR A DENTAL VARNISH | DENTSPLY SIRONA INC (US) | 2023-03-22 | — | — | EP | claimed |
| EP-3102079-B1 | DISPERSIBLE HYDROENTANGLED BASESHEET WITH TRIGGERABLE BINDER | KIMBERLY CLARK CO (US) | 2023-01-04 | — | — | EP | claimed |
| EP-3143098-B1 | POLYMER AND SURFACTANT COMPOSITIONS AND THEIR USES FOR THE IMPROVED RECOVERY OF HYDROCARBONS | TOTAL SE (FR) | 2021-02-10 | — | — | EP | claimed |
| EP-3234022-B1 | PARTICLES FOR ELECTROPHORETIC DISPLAYS | MERCK PATENT GMBH (DE) | 2020-01-29 | — | — | EP | claimed |
| EP-2834705-B1 | PARTICLES FOR ELECTROPHORETIC DISPLAYS COMPRISING A CORE AND A RANDOM-COPOLYMER COATING | MERCK PATENT GMBH (DE) | 2018-12-05 | — | — | EP | claimed |
| EP-2744399-B1 | CONTROL OF BIOFOULING IN IMPLANTABLE BIOSENSORS | UNIV CONNECTICUT (US) | 2017-07-12 | — | — | EP | claimed |
| EP-2384375-B1 | ELECTROSPINNING OF PTFE WITH HIGH VISCOSITY MATERIALS | ZEUS IND PRODUCTS INC (US) | 2017-07-05 | — | — | EP | claimed |
| EP-1585502-B9 | FAST-DISINTEGRATING SOLID DOSAGE FORMS BEING NOT FRIABLE AND COMPRISING PULLULAN | ELAN PHARMA INT LTD (IE) | 2012-05-09 | — | — | EP | claimed |
| EP-1937733-B1 | PROCESS FOR PREPARING AN AQUEOUS DISPERSION OF A QUATERNARY AMMONIUM SALT CONTAINING VINYL COPOLYMER | BOSTIK INC (US) | 2009-12-30 | — | — | EP | claimed |
| EP-1814511-B1 | METHOD FOR THE PERMANENT SHAPING OF HAIR USING A CATIONIC CELLULOSE DERIVATIVE | PROCTER & GAMBLE (US) | 2009-12-23 | — | — | EP | claimed |
| US-20080031846-A1 | Compositions with enhanced antimicrobial efficacy against acanthamoebae | BORAZJANI ROYA | 2008-02-07 | — | — | US | claimed |
| EP-1852133-A2 | Compositions with enhanced antimicrobial efficacy against acanthamoebae | BAUSCH & LOMB INCORPORATED (US) | 2007-11-07 | — | — | EP | claimed |
| EP-1443912-B1 | COMPOSITIONS HAVING A COMBINATION OF IMMEDIATE RELEASE AND CONTROLLED RELEASE CHARACTERISTICS | ELAN PHARMA INT LTD (IE) | 2007-08-29 | — | — | EP | claimed |
| EP-1539259-B1 | WET WIPES COMPRISING ION TRIGGERABLE, CATIONIC POLYMERS | KIMBERLY CLARK CO (US) | 2007-07-25 | — | — | EP | claimed |
| EP-1429731-B1 | NANOPARTICULATE INSULIN FORMULATIONS | ELAN PHARMA INT LTD (IE) | 2007-01-03 | — | — | EP | claimed |
| EP-0920487-B1 | COMPOSITION AND METHOD FOR INHIBITING THE DEPOSITION OF PROTEIN ON CONTACT LENS | BAUSCH & LOMB (US) | 2003-04-09 | — | — | EP | claimed |
| US-6096138-A | IMMERSION IN AQUEOUS SOLUTION OF POLYQUATERNARY AMMONIUM SALT CATIONIC POLYMER | BAUSCH & LOMB INCORPORATED (US) | 2000-08-01 | — | — | US | claimed |
| EP-0559851-B1 | HAIR-SETTING AGENT AND A HAIR-PERMING METHOD USING THIS AGENT | WELLA AG (DE) | 1995-08-23 | — | — | EP | claimed |
| EP-0398019-B1 | Direct electroplating of through-holes | IBM (US) | 1995-07-12 | — | — | EP | claimed |
| EP-0356665-B1 | CATIONIC FIXATION COMPOSITION AND PROCESS FOR THE PERMANENT WAVING OF HAIR | Wella Aktiengesellschaft (DE) | 1992-06-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080031846-A1 | Compositions with enhanced antimicrobial efficacy against acanthamoebae | LAGE3, PKD2, CUTA | CHRM5 4271/4885CHRM1 2792/4885CHRM3 3319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.